Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

7.18
-0.3600-4.77%
Pre-market: 7.180.00000.00%08:00 EDT
Volume:2.88M
Turnover:21.01M
Market Cap:2.25B
PE:-170.55
High:7.56
Open:7.45
Low:7.16
Close:7.54
Loading ...
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 03, 2022

Major Issues Report

8-K - Current report
Jul 19, 2022

Major Issues Report

8-K - Current report
Jun 02, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2022

Major Issues Report

8-K - Current report
Mar 16, 2022

Major Issues Report

8-K - Current report
Mar 02, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 11, 2022

Major Issues Report

8-K - Current report
Jan 05, 2022

Major Issues Report

8-K - Current report
Dec 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
May 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
May 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities